Dopamine transporter gene associated with diminished subjective response to amphetamine.
about
Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13)The Neurobiology of the Switch Process in Bipolar DisorderAmphetamine-induced place preference in humansToxicity of amphetamines: an updateThe 5-HTTLPR polymorphism of the serotonin transporter gene and short term behavioral response to methylphenidate in children with ADHDNegative emotionality: monoamine oxidase B gene variants modulate personality traits in healthy humansTRDB--the Tandem Repeats DatabaseDo initial responses to drugs predict future use or abuse?A review of pharmacogenetic studies of substance-related disordersInvestigating the mechanism(s) underlying switching between states in bipolar disorderSymbiotic relationship of pharmacogenetics and drugs of abuse.α- and β-Adrenergic receptors differentially modulate the emission of spontaneous and amphetamine-induced 50-kHz ultrasonic vocalizations in adult ratsDopamine transporter gene variation modulates activation of striatum in youth with ADHDDopamine transporter genotype and stimulant dose-response in youth with attention-deficit/hyperactivity disorder.Progress and promise of attention-deficit hyperactivity disorder pharmacogenetics.Catechol-O-methyltransferase val158met genotype modulates sustained attention in both the drug-free state and in response to amphetamine.Human behavioral pharmacology, past, present, and future: symposium presented at the 50th annual meeting of the Behavioral Pharmacology Society.More aroused, less fatigued: fatty acid amide hydrolase gene polymorphisms influence acute response to amphetamine.Csnk1e is a genetic regulator of sensitivity to psychostimulants and opioids.Further evidence of association between amphetamine response and SLC6A2 gene variantsDopamine transporter 3'-UTR VNTR genotype and ADHD: a pharmaco-behavioural genetic study with methylphenidate.Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.Pharmacogenetics: a tool for identifying genetic factors in drug dependence and response to treatmentThe reinforcing, subject-rated, performance, and cardiovascular effects of d-amphetamine: influence of sensation-seeking status.Genetic variation of the dopamine transporter (DAT1) influences the acute subjective responses to cocaine in volunteers with cocaine use disorders.Polymorphisms in dopamine transporter (SLC6A3) are associated with stimulant effects of D-amphetamine: an exploratory pharmacogenetic study using healthy volunteers.Serotonin transporter polymorphism mediates vulnerability to loss of incentive motivation following acute tryptophan depletion.Inbred Lewis and Fischer 344 rat strains differ not only in novelty- and amphetamine-induced behaviors, but also in dopamine transporter activity in vivo.Effects of an opioid (proenkephalin) polymorphism on neural response to errors in health and cocaine use disorder.Genetic factors modulating the response to stimulant drugs in humans.Attention-deficit/hyperactivity disorder: advancing on pharmacogenomics.Amphetamine self-administration in light and moderate drinkers.Neurorobiology and evidence-based biological treatments for substance abuse disorders.The pharmacogenomic era: promise for personalizing attention deficit hyperactivity disorder therapy.Asians compared to Whites show increased response to d-amphetamine on select subjective and cardiovascular measuresDisulfiram enhances subjective effects of dextroamphetamine in humans.Candidate gene studies of a promising intermediate phenotype: failure to replicate.An association study of the brain-derived neurotrophic factor Val66Met polymorphism and amphetamine responseGene x abstinence effects on drug cue reactivity in addiction: multimodal evidenceProgesterone and medroxyprogesterone acetate differentially regulate alpha4 subunit expression of GABA(A) receptors in the CA1 hippocampus of female rats.
P2860
Q21134099-2F737D23-6BBA-4FEB-93AB-871591FB0381Q22241114-83DCD7EF-BC57-4278-8F99-35F492FFBC99Q22252505-79C2B632-D043-47FD-A669-B1A02DC3670AQ22252794-43275A56-65C4-46EE-AB2B-F98EBF7BE067Q24288955-3947E24E-DD00-4AED-8098-57E15297B6F6Q24628259-5338E76E-3EC8-4CFA-A485-E7292F25F8FBQ24683650-BCCFE3D6-E936-4D0A-9E27-6E32F5713B74Q27025975-0C49FA46-EF12-4FDB-9451-6FB4E7B7303AQ27312296-59E1D100-B0F3-44A2-9361-2D7E63778C21Q28084519-7ED9AA35-B524-4311-A0BD-85EA184CDCE5Q28476270-F818843F-B4B5-4817-A0C9-AE96F3BBA191Q30458757-C8D25B89-27D8-460C-AED8-E253C3105789Q30495097-59F5F760-16F1-49DD-880C-2F9D4A55560AQ33782844-36691BDB-8A13-4BF1-9B82-23AAB6409F34Q33870580-CC50B529-872C-49C2-B130-F76B386D98FDQ33871386-9590A70C-B388-4F55-9A89-A35604BB80B6Q34033200-DD7833B5-CC3A-45D9-8530-F0B91655433AQ34156619-ECFF3568-F265-453C-80A8-011F920194B2Q34233183-442C6F03-F06E-4D31-B646-23DDDA57E38EQ34565939-0A22F0BB-DE1B-478C-9838-12F4E99DFA1DQ34576427-92BD413D-7FF0-48F4-A2D7-1633BCB9B594Q34982551-01F8C331-D397-46B8-A4BA-C37A206AD0E7Q35059965-E27C6442-6D65-49A1-B253-6D6C5F493610Q35327605-A2C86EEE-DF75-4AC6-8C22-A2A0F33B8109Q35554545-7B53D7EC-90D1-483C-9B98-C95F226FAF2AQ35679449-A1B6F2C7-E969-4589-80FA-C4B41B393560Q35750662-8CA3067D-D891-4881-817F-7E46A098417EQ35919284-82C926D9-7268-4E41-83CB-41A0292984C6Q36052661-49137147-1281-472B-9A25-337747CEC1B2Q36071808-B417169E-E2CB-49F4-A618-7F761299083FQ36192663-6989BA8E-C55D-4742-99E1-8E8FC7E1454FQ36333302-9DEBF037-32B1-4DAC-A4B8-C7D1E18357F8Q36639800-ADCD874D-CEBA-4763-A90B-DA953CA06B8FQ36699910-44075367-F36A-4CFB-8D82-F7375EF524A7Q36767491-1D824D88-103F-410A-89CE-D8C9994D93A5Q36772550-582722F5-AFAC-474C-8184-70DED032B134Q36901154-026C91D3-D788-48AD-97E2-C1F29B2C66A9Q36915364-719AF609-E61A-4DBC-B5E3-5EC574FC2C09Q36928468-CD3EE0D4-4C2A-412E-B75E-D0481F290714Q37208037-E23D1000-150F-4243-A20A-489EFC10B125
P2860
Dopamine transporter gene associated with diminished subjective response to amphetamine.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Dopamine transporter gene associated with diminished subjective response to amphetamine.
@en
Dopamine transporter gene associated with diminished subjective response to amphetamine.
@nl
type
label
Dopamine transporter gene associated with diminished subjective response to amphetamine.
@en
Dopamine transporter gene associated with diminished subjective response to amphetamine.
@nl
prefLabel
Dopamine transporter gene associated with diminished subjective response to amphetamine.
@en
Dopamine transporter gene associated with diminished subjective response to amphetamine.
@nl
P2860
P356
P1476
Dopamine transporter gene associated with diminished subjective response to amphetamine.
@en
P2093
David C Lott
Soo-Jeong Kim
P2860
P2888
P304
P356
10.1038/SJ.NPP.1300637
P407
P577
2005-03-01T00:00:00Z
P5875
P6179
1009045933